Human Galectin-3BP/MAC-2BP Antibody Summary
Val19-Asp585
Accession # Q08380
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
View Larger
Detection of Human Galectin‑3BP/MAC‑2BP by Western Blot. Western blot shows lysates of HeLa human cervical epithelial carcinoma cell line and HepG2 human hepatocellular carcinoma cell line. PVDF membrane was probed with 0.2 µg/mL of Goat Anti-Human Galectin-3BP/MAC-2BP Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2226) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF019). A specific band was detected for Galectin-3BP/MAC-2BP at approximately 75 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
View Larger
Galectin‑3BP/MAC‑2BP in HeLa Human Cell Line. Galectin-3BP/MAC-2BP was detected in immersion fixed HeLa human cervical epithelial carcinoma cell line using Goat Anti-Human Galectin-3BP/MAC-2BP Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2226) at 1.7 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (red; Catalog # NL001) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. View our protocol for Fluorescent ICC Staining of Cells on Coverslips.
View Larger
Detection of Human Galectin‑3BP/MAC‑2BP by Simple WesternTM. Simple Western lane view shows lysates of HeLa human cervical epithelial carcinoma cell line and HepG2 human hepatocellular carcinoma cell line, loaded at 0.2 mg/mL. A specific band was detected for Galectin-3BP/MAC-2BP at approximately 115 kDa (as indicated) using 10 µg/mL of Goat Anti-Human Galectin-3BP/MAC-2BP Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2226) followed by 1:50 dilution of HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF109). This experiment was conducted under reducing conditions and using the 12-230 kDa separation system.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Galectin-3BP/MAC-2BP
Galectin-3 binding protein (Galectin-3BP), also known as MAC-2 binding protein (MAC-2BP or M2BP), and the 90 kDa tumor associated antigen (TAA90K or 90K), is a secreted glycoprotein of the scavenger receptor cysteine-rich (SRCR) superfamily (1, 2). Galectin-3BP binds Galectin-3 (formerly MAC-2) with high affinity, but also binds Galectins -1 and -7, several collagen types, fibronectin, beta 1 integrins and nidogen (3, 6, 7). It is widely expressed in all extracellular fluids and in pericellular areas of cell-rich tissues (1-3). The 585 amino acid (aa) human Galectin-3BP contains an 18 aa signal sequence and four definitive domains (4-6). Domain 1 is a group A scavenger receptor domain (4), domain 2 is a BTB/POZ domain that strongly mediates dimerization (5), and domain 3 is an IVR domain, that is also found following the POZ domain in Drosophila kelch protein. Although little is known about domain 4, recombinant domains 3 and 4 reproduce the solid-phase adhesion profile of full-length Galectin-3BP (5, 6). Glycosylation at seven N-linked sites, generates a molecular size of 85-97 kDa (1, 2, 6). Galectin-3BP dimers form linear and ring-shaped oligomers, most commonly decamers and dodecamers (3, 5). In vitro, Galectin-3BP has been shown to stimulate natural killer cells and lymphokine-activated killer cell activity (2). High Galectin-3BP expression has been correlated with tumor aggressiveness in several, but not all, study systems (7). Mature human Galectin-3BP shares 69% aa identity with mouse cyclophilin C-associated protein (CyCAP), which does not appear to bind Galectin-3 (8). Human Galectin-3BP also shares 73%, 67% and 68% aa identity with relatively uncharacterized orthologs in dog, rat and cow, respectively. A human N-terminally truncated sequence that begins within the BTB/POZ domain (aa 196) has been reported.
- Koths, K. et al. (1993) J. Biol. Chem. 268:14245.
- Ullrich, A. et al. (1994) J. Biol. Chem. 269:18401.
- Sasaki, T. et al. (1998) EMBO J. 17:1606.
- Hohenester, E. et al. (1999) Nat. Struct. Biol. 6:228.
- Muller, S. A. et al. (1999) J. Mol. Biol. 291:801.
- Hellstern, S. et al. (2002) J. Biol. Chem. 277:15690.
- Grassadonia, A. et al. (2004) Glycoconj. J. 19:551.
- Jalkanen, K. et al. (2001) Eur. J. Immunol. 31:3075.
Product Datasheets
Citations for Human Galectin-3BP/MAC-2BP Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
17
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Quantitative glycoproteomics reveals new classes of STT3A- and STT3B-dependent N-glycosylation sites
Authors: Natalia A. Cherepanova, Sergey V. Venev, John D. Leszyk, Scott A. Shaffer, Reid Gilmore
Journal of Cell Biology
-
Schwann Cell Stimulation of Pancreatic Cancer Cells: A Proteomic Analysis
Authors: Aysha Ferdoushi, Xiang Li, Nathan Griffin, Sam Faulkner, M. Fairuz B. Jamaluddin, Fangfang Gao et al.
Frontiers in Oncology
-
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma
Authors: Beatrice Dufrusine, Emily Capone, Sara Ponziani, Rossano Lattanzio, Paola Lanuti, Francesco Giansanti et al.
Molecular Oncology
-
Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer
Authors: Yamanaka, T;Araki, K;Yokobori, T;Muranushi, R;Hoshino, K;Hagiwara, K;Gantumur, D;Ishii, N;Tsukagoshi, M;Watanabe, A;Harimoto, N;Masamune, A;Uojima, H;Mizokami, M;Ito, K;Shirabe, K;
Cancer science
Species: Human
Sample Types: Protein, Whole Tissue
Applications: Immunohistochemistry, Western Blot -
Extracellular vesicles stimulate smooth muscle cell migration by presenting collagen VI
Authors: Kapustin, A;Tsakali, SS;Whitehead, M;Chennell, G;Wu, MY;Molenaar, C;Kutikhin, A;Bogdanov, L;Sinitsky, M;Rubina, K;Clayton, A;Verweij, FJ;Pegtel, DM;Zingaro, S;Lobov, A;Zainullina, B;Owen, D;Parsons, M;Cheney, RE;Warren, D;Humphries, MJ;Iskratsch, T;Holt, M;Shanahan, CM;
bioRxiv : the preprint server for biology
Species: Human
Sample Types: Extracellular Vesicles
Applications: Western Blot -
Proteomics of Primary Uveal Melanoma: Insights into Metastasis and Protein Biomarkers
Authors: GF Jang, JS Crabb, B Hu, B Willard, H Kalirai, AD Singh, SE Coupland, JW Crabb
Cancers, 2021-07-14;13(14):.
Species: Human
Sample Types: Tissue Homogenates
Applications: Western Blot -
Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
Authors: E Capone, A Lamolinara, F Pastorino, R Gentile, S Ponziani, G Di Vittori, D D'Agostino, S Bibbò, C Rossi, E Piccolo, V Iacobelli, R Lattanzio, V Panella, M Sallese, V De Laurenz, F Giansanti, A Sala, M Iezzi, M Ponzoni, R Ippoliti, S Iacobelli, G Sala
Cancers (Basel), 2020-10-15;12(10):.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling
Authors: G Dolgormaa, N Harimoto, N Ishii, T Yamanaka, K Hagiwara, M Tsukagoshi, T Igarashi, A Watanabe, N Kubo, K Araki, T Handa, T Yokobori, T Oyama, H Kuwano, K Shirabe
Br. J. Cancer, 2020-07-06;0(0):.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
Galectin 3-binding protein suppresses amyloid-&beta production by modulating &beta-cleavage of amyloid precursor protein
Authors: T Seki, M Kanagawa, K Kobayashi, H Kowa, N Yahata, K Maruyama, N Iwata, H Inoue, T Toda
J. Biol. Chem., 2020-01-29;295(11):3678-3691.
Species: Human
Sample Types: Recombinant Protein
Applications: Western Blot -
Lectin, galactoside-binding soluble 3 binding protein promotes 17-N-Allylamino-17-demethoxygeldanamycin resistance through PI3K/Akt pathway in lung cancer cell line
Authors: JK Woo, JE Jang, JH Kang, JK Seong, YS Yoon, HC Kim, SJ Lee, SH Oh
Mol. Cancer Ther, 2017-03-23;0(0):.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques
Authors: SR Langley, K Willeit, A Didangelos, LP Matic, P Skroblin, J Barallobre, M Lengquist, G Rungger, A Kapustin, L Kedenko, C Molenaar, R Lu, T Barwari, G Suna, X Yin, B Iglseder, B Paulweber, P Willeit, J Shalhoub, G Pasterkamp, AH Davies, C Monaco, U Hedin, CM Shanahan, J Willeit, S Kiechl, M Mayr
J. Clin. Invest, 2017-03-20;0(0):.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
M2BP inhibits HIV-1 virion production in a vimentin filaments-dependent manner
Sci Rep, 2016-09-08;6(0):32736.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6.
J. Virol., 2012-04-11;86(12):6620-31.
Species: Human, Primate - Macaca mulatta (Rhesus Macaque)
Sample Types: Serum
Applications: Western Blot -
A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma.
Authors: Silverman A, Nakata R, Shimada H, Sposto R, DeClerck Y
Cancer Res, 2012-03-02;72(9):2228-38.
Species: Human
Sample Types: Cell Lysates, Whole Cells
Applications: ICC, Western Blot -
Diverse functions of reactive cysteines facilitate unique biosynthetic processes of aggregate-prone interleukin-31.
Authors: Shen M, Siu S, Byrd S, Edelmann KH, Patel N, Ketchem RR, Mehlin C, Arnett HA, Hasegawa H
Exp. Cell Res., 2010-12-21;317(7):976-93.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Identification of galectin-3-binding protein as a factor secreted by tumor cells that stimulates interleukin-6 expression in the bone marrow stroma.
Authors: Fukaya Y, Shimada H, Wang LC, Zandi E, DeClerck YA
J. Biol. Chem., 2008-05-01;283(27):18573-81.
Species: Human
Sample Types: Cell Culture Supernates
Applications: Western Blot -
F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.
Authors: Sandra Pankow, Casimir Bamberger, Diego Calzolari et al.
Nature
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human Galectin-3BP/MAC-2BP Antibody
Average Rating: 3.8 (Based on 4 Reviews)
Have you used Human Galectin-3BP/MAC-2BP Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by:
